A Dual-Selective αvβ6-αvβ1 Inhibitor With Surprising Safety Data

bexotegrast (PLN-74809)

oral, dual-selective αvβ6-αvβ1 integrin inhibitor Ph. II for IPF and PSC related to reported integrin inhibitors Press Release, May 2024 Pliant Therapeutics, South San Francisco, CA

Drug Hunter Team

Reviewers:

Lew Pennington,

Dennis C. Koester

Editors:

Dennis X. Hu,

Rory McAtee

A Dual-Selective αvβ6-αvβ1 Inhibitor With Surprising Safety Data

bexotegrast (PLN-74809)

Other molecules you may be interested in